Location History:
- Osaka, JP (1993)
- Takarazuka, JP (2001)
- Kyoto, JP (1999 - 2012)
Company Filing History:
Years Active: 1993-2012
Title: Kenji Oeda: Pioneering Innovations in Mood Disorder Treatments
Introduction
Kenji Oeda is a prominent inventor based in Kyoto, Japan, known for his groundbreaking work in the field of biomedicine. With a remarkable portfolio of 16 patents, Oeda has made significant contributions to the understanding and treatment of mood disorders through innovative methodologies.
Latest Patents
Oeda's latest patents include a method for ameliorating symptoms caused by mood disturbances. This innovative approach focuses on the excessive presence of Gm1 protein in the brain of mammals, aiming to improve symptoms associated with mood disorders. Another of his noteworthy patents involves a novel Gm1 protein, which plays a crucial role in signal transduction mediated by G protein-coupled receptors. This protein, remarkably expressed in various human tissues such as the brain, thymus, and heart, opens new avenues for understanding cellular signaling pathways and could lead to enhanced therapeutic interventions.
Career Highlights
Throughout his career, Oeda has been affiliated with reputable organizations such as Sumitomo Chemical Company, where he has contributed to advancing chemical and biomedical technologies. His work has not only led to multiple patents but also meaningful scientific advancements in the treatment of mood disorders.
Collaborations
During his innovative journey, Oeda has collaborated with notable coworkers including Toru Yamada and Fumiharu Ishige. These partnerships have fostered an environment of shared knowledge and expertise, further enhancing the impact of his inventions in the scientific community.
Conclusion
Kenji Oeda's contributions to the field of biomedicine are invaluable, particularly in the realm of mood disorder treatment. With his array of patents and collaborative efforts, Oeda continues to pave the way for innovative solutions that may profoundly affect mental health therapy in the future. His dedication to research and discovery underscores the importance of innovation in addressing complex health challenges.